The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 04, 2025
Filed:
Dec. 09, 2019
Applicants:
Emory University, Atlanta, GA (US);
The Uab Research Foundation, Birmingham, AL (US);
Children's Healthcare of Atlanta, Inc., Atlanta, GA (US);
Inventors:
Harold Trent Spencer, Marietta, GA (US);
Anindya Dasgupta, Anderson, SC (US);
Lawrence S. Lamb, Birmingham, AL (US);
Assignees:
Emory University, Atlanta, GA (US);
The UAB Research Foundation, Birmingham, AL (US);
Children's Healthcare of Atlanta, Inc., Atlanta, GA (US);
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 35/17 (2015.01); A61K 31/4188 (2006.01); A61K 31/495 (2006.01); A61K 31/519 (2006.01); A61K 39/00 (2006.01); C12N 5/0783 (2010.01); A61K 35/12 (2015.01);
U.S. Cl.
CPC ...
A61K 31/4188 (2013.01); A61K 31/495 (2013.01); A61K 31/519 (2013.01); A61K 39/4611 (2023.05); A61K 39/4613 (2023.05); A61K 39/4644 (2023.05); C12N 5/0636 (2013.01); C12N 5/0638 (2013.01); A61K 35/12 (2013.01); A61K 2035/124 (2013.01); A61K 2239/48 (2023.05); C12N 2510/00 (2013.01);
Abstract
The present disclosure is generally related to methods for combining chemotherapy and immunotherapy for the treatment of a cancer. The methods also relate to generating a drug-resistant cytotoxic immune cell line and uses thereof in conjunction with cytotoxic drugs